David Lowenschuss
Corporate Officer/Principal chez Mekanistic Therapeutics LLC
Profil
David Lowenschuss was the founder of Gemphire Therapeutics, Inc. which he founded in 2014 and served as Secretary & Chief Legal Officer.
Currently, he is the Chief Business Officer at Mekanistic Therapeutics LLC.
Mr. Lowenschuss has a graduate degree from George Washington University and both undergraduate and graduate degrees from the University of Michigan.
Postes actifs de David Lowenschuss
| Sociétés | Poste | Début |
|---|---|---|
Mekanistic Therapeutics LLC
 Mekanistic Therapeutics LLC Pharmaceuticals: MajorHealth Technology Mekanistic Therapeutics LLC designs, discovers and develops cancer therapeutics through developing anti-cancer agents. The company was founded by Christopher Whitehead and Judith Sebolt-Leopold and is headquartered in Ann Arbor, MI. | Corporate Officer/Principal | - |
Anciens postes connus de David Lowenschuss
| Sociétés | Poste | Fin |
|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Fondateur | - |
Formation de David Lowenschuss
| George Washington University | Graduate Degree |
| University of Michigan | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
Mekanistic Therapeutics LLC
Mekanistic Therapeutics LLC Pharmaceuticals: MajorHealth Technology Mekanistic Therapeutics LLC designs, discovers and develops cancer therapeutics through developing anti-cancer agents. The company was founded by Christopher Whitehead and Judith Sebolt-Leopold and is headquartered in Ann Arbor, MI. | Health Technology |
